expert Q&A
expert Q&A
05/31/2024

Joseph Magagnoli, MS

Joseph Magagnoli, MS
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
05/31/2024
Expert Q&A
Expert Q&A
05/11/2024
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
05/11/2024
Expert Q&A
Expert Q&A
05/11/2024
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
05/11/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024